PATENT CLAIM ANALYSIS

Application Number: 15921138
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "221000"]

Abstract:
A method for treating cancer including administering to a patient in need thereof an effective amount of a compound having the formula: wherein R 1 , R 2  , Ya, Xa, and J −  are as defined herein, and may be where R1 and R2 are independently selected from methyl, ethyl, n-propyl, or i-propyl; Xa is N or CH; Ya is hydrogen or independently selected from halogen, cyano, hydroxyl, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, heteroaryl of 6 members and aryl; n is 1 or 2; wherein J −  is fluoride, chloride, bromide, iodide, acetate, sulfate or sulfonate such as tosylate, mesylate, besylate.

Claim (Index 17):
The method as defined in  claim 1 , wherein said glioma and other CNS cancers are ependymomas, astrocytomas, oligodendrogliomas, glioblastomas or oligoastrocytomas.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 90.0
- Lexical Diversity: 1.73077
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15301523', '13190941', '16062399', '13178670', '14692597']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7044797494111736
- 35 USC 102 Novelty (BERT): 0.5367589908216086
- Combined Prediction Score: 0.6877076735522172
- Mean Citation Score: 202.875768
- Max Citation Score: 323.32993
- Similarity Product: 188.6085605223417

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test